REDUCTION IN CORTICAL 5-HT3 BINDING-SITES FOLLOWING A UNILATERAL 6-HYDROXYDOPAMINE LESION OF THE MEDIAL FOREBRAIN-BUNDLE IN RATS

被引:16
作者
CICINSAIN, L [1 ]
JENNER, P [1 ]
机构
[1] UNIV LONDON KINGS COLL, DIV BIOMED SCI,PHARMACOL GRP,EXPTL RES LABS, PARKINSONS DIS SOC, LONDON WC2R 2LS, ENGLAND
关键词
SEROTONIN; 5-HT3; RECEPTORS; RAT BRAIN; 6-HYDROXYDOPAMINE; DOPAMINE;
D O I
10.1016/0022-510X(93)90074-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Serotonergic mechanisms have been implicated in pathophysiology of Parkinson's disease, an illness where the dopamine deficiency represents the prime biochemical deficit. Present interest centres on the possible involvement of serotonergic receptors in modulating dopamine transmission. In this paper the binding of the selective 5-HT3 antagonist [H-3]GR 65630 was studied in rats with a unilateral 6-hydroxydopamine lesion of the medial forebrain bundle. The maximal density of specific [H-3]GR 65630 binding was reduced in homogenates of entorhinal (17.1%, P < 0.05) and prefrontal cortex (27.5%, P < 0.05) on the lesioned side of the rat brain compared to the control tissues. An increase in affinity for [H-3]GR 65630 binding was also found in homogenates of prefrontal cortex (33.8%, P < 0.05). No changes in the characteristics of [H-3]GR 65630 binding to homogenates from the amygdala and hippocampus were observed. These data suggest that altered dopamine function may affect serotonergic mechanisms in the cortex in Parkinson's disease.
引用
收藏
页码:105 / 110
页数:6
相关论文
共 36 条
[1]   EFFECT OF DRUGS INFLUENCING CENTRAL SEROTONERGIC MECHANISMS ON HALOPERIDOL-INDUCED CATALEPSY [J].
BALSARA, JJ ;
JADHAV, JH ;
CHANDORKAR, AG .
PSYCHOPHARMACOLOGY, 1979, 62 (01) :67-69
[2]   EFFECTS OF 5,7-DIHYDROXYTRYPTAMINE LESIONS OF EXTRAPYRAMIDAL AND MESOLIMBIC SITES ON SPONTANEOUS MOTOR BEHAVIOR, AND AMPHETAMINE-INDUCED STEREOTYPY [J].
CARTER, CJ ;
PYCOCK, CJ .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1979, 308 (01) :51-54
[3]   CORTICAL SEROTONIN-S2 RECEPTOR-BINDING IN LEWY BODY DEMENTIA, ALZHEIMERS AND PARKINSONS DISEASES [J].
CHENG, AVT ;
FERRIER, IN ;
MORRIS, CM ;
JABEEN, S ;
SAHGAL, A ;
MCKEITH, IG ;
EDWARDSON, JA ;
PERRY, RH ;
PERRY, EK .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 106 (01) :50-55
[4]  
CICINSAIN L, 1992, NEUROSCI RES COMMUN, V10, P17
[5]   SEROTONINERGIC MODULATION OF DOPAMINE RESPONSE FROM NUCLEUS ACCUMBENS [J].
COSTALL, B ;
NAYLOR, RJ ;
MARSDEN, CD ;
PYCOCK, CJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (06) :523-526
[6]   THE PSYCHOPHARMACOLOGY OF 5-HT3 RECEPTORS [J].
COSTALL, B ;
NAYLOR, RJ ;
TYERS, MB .
PHARMACOLOGY & THERAPEUTICS, 1990, 47 (02) :181-202
[7]   CONTRASTING EFFECTS OF 5-HYDROXYTRYPTAMINE ON THE RELEASE OF DOPAMINE AND ACETYLCHOLINE IN THE NUCLEUS ACCUMBENS OF RAT [J].
DEBELLEROCHE, J ;
GARDINER, IM .
JOURNAL OF NEURAL TRANSMISSION, 1982, 55 (03) :227-242
[8]   CHARACTERIZATION OF INHIBITORY 5-HYDROXYTRYPTAMINE RECEPTORS THAT MODULATE DOPAMINE RELEASE IN THE STRIATUM [J].
ENNIS, C ;
KEMP, JD ;
COX, B .
JOURNAL OF NEUROCHEMISTRY, 1981, 36 (04) :1515-1520
[9]   SEROTONIN MICROINFUSION INTO THE VENTRAL TEGMENTAL AREA INCREASES ACCUMBENS DOPAMINE RELEASE [J].
GUAN, XM ;
MCBRIDE, WJ .
BRAIN RESEARCH BULLETIN, 1989, 23 (06) :541-547
[10]   EFFECT OF 5-HT3 RECEPTOR ANTAGONISTS ON RESPONSES TO SELECTIVE ACTIVATION OF MESOLIMBIC DOPAMINERGIC PATHWAYS IN THE RAT [J].
HAGAN, RM ;
JONES, BJ ;
JORDAN, CC ;
TYERS, MB .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (02) :227-232